Cat.#: ACPP-1429
| Despition | FGF14 Human Recombinant |
| SIZE | 2 µg |
| Purity | > 90% (SDS-PAGE) |
| Form | Sterile Filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1287 | Dopamine Receptor D1 Blocking Peptide (AC1287) | 250 µg | inquiry |
| ACPP-1205 | Human MECP2 Protein (AC1205) | 2 µg | inquiry |
| ACPP-1385 | Human TGFBI Protein (AC1385) | 5 µg | inquiry |
| ACPP-1347 | Human HDL Protein (AC1347) | 10 mg | inquiry |
| ACPP-1764 | Human ANTXR2 Protein (AC1764) | 2 µg | inquiry |
| ACPP-1672 | Human SERPINA3 Protein (AC1672) | 20 µg | inquiry |
| ACPP-1839 | Human Ornithine Aminotransferase Protein (AC1839) | 5 µg | inquiry |
| ACPP-1331 | GPR56 Blocking Peptide (AC1331) | 250 µg | inquiry |
| ACPP-1133 | Synthetic Nanodisc Human OR52D1 Protein (AC1133) | 10 µg | inquiry |
| ACPP-1450 | Human BMP13 Protein (AC1450) | 10 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.